CYTOMED THERAPEUTICS LIMITED

Historical 13F Holders

Symbol
GDTC
CUSIP
Y1R80M106
All holders as of
Q2 2026
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for Y1R80M106 since 12/18/2024, newest first.

Filer % of Class Filed
mDR Ltd 13G/A Amendment 3 10.0% 10/23/2026
Event 10/12/2026
Choo Chee Kong 13D/A Amendment 5 25.2% 10/16/2026
Event 10/12/2026
Choo Chee Kong 13D/A Amendment 4 24.9% 10/13/2026
Event 10/6/2026
Choo Chee Kong 13D/A Amendment 3 24.3% 7/24/2026
Event 7/20/2026
Choo Chee Kong 13D/A Amendment 2 22.1% 10/29/2025
Event 10/29/2025
mDR Ltd 13G/A Amendment 2 11.3% 3/24/2025
Event 12/16/2024
Choo Chee Kong 13D/A Amendment 1 23.2% 3/14/2025
Event 2/20/2025
28 Consultants Ltd 13G 7.6% 3/4/2025
Event 2/17/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 1 27.0 k $24.4k
2026 Q2 3 11.9 k $12.2k
2026 Q1 3 16.3 k $16.3k
2025 Q4 5 53.1 k $70.8k
2025 Q3 2 18.1 k $36.1k
2025 Q2 3 45.3 k $98.5k
2025 Q1 3 31.7 k $70.3k
2024 Q4 2 10.1 k $34.3k
2024 Q3 2 61.0 $96
2024 Q2 1 0 $0
2024 Q1 2 13.0 $28
2023 Q4 3 4.38 k $21.5k
2023 Q3 3 5.88 k $20.7k
2023 Q2 2 54.0 $165